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Background: Molecular mechanisms involved in the oxidative stress induced glucocorticoids insensitivity remain
elusive. The mitogen-activated protein kinase phosphatase (MKP) 1 mediates a part of glucocorticoids action and
can be modified by exogenous oxidants. Whether oxidant ozone (O3) can affect the function of MKP-1 and hence
blunt the response to corticotherapy is not clear.
Methods: Here we employed a murine model of asthma established with ovalbumin (OVA) sensitization and
challenge to evaluate the influence of O3 on the inhibitory effect of dexamethasone on AHR and airway
inflammation, and by administration of SB239063, a selective p38 MAPK inhibitor, to explore the underlying
involvements of the activation of p38 MAPK and the expression of MKP-1.
Results: Ozone exposure not only aggravated the pulmonary inflammation and AHR, but also decreased the
inhibitory effects of dexamethasone, accompanied by the elevated oxidative stress, airway neutrophilia, enhanced
phosphorylation of p38 MAPK, and upregulated expression of IL-17. Administration of SB239063 caused significant
inhibition of the p38 MAPK phosphorylation, alleviation of the airway neutrophilia, and decrement of the ozone-induced
IL-17 expression, and partly restored the ozone-impaired effects of dexamethasone. Ozone exposure not only decreased
the protein expression of MKP-1, but also diminished the dexamethasone-mediated induction process of MKP-1 mRNA
and protein expression.
Conclusions: The glucocorticoids insensitivity elicited by ozone exposure on current asthma model may involve the
enhanced phosphorylation of p38 MAPK and disturbed expression of MKP-1.
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Bronchial asthma is a common airway disease charac-
terized by airway hyperresponsiveness (AHR), airway
inflammation, and airway remodeling. Up to date, the
most effective treatment of asthma is performed through
glucocorticoids (GC), taken systemically or by inhalation.
However, up to 10% of the asthmatic patients are clinically
insensitive to corticotherapy [1], while the molecular
mechanisms contributing to this lack of sensitivity remain
unclear. The classical model of the glucocorticoid anti-
inflammatory action is established as that the binding
of glucocorticoid to its receptor (GR/NR3C1) may* Correspondence: xzhou53@163.com
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unless otherwise stated.transrepress the inflammatory gene transcription or
transactivate multiple anti-inflammatory/repressive fac-
tors [2]. However, an alternative mechanism of the GC
action has gained an increasing body of concern focusing
attention on the role of the mitogen-activated protein
kinase phosphatase 1 (MKP-1), a phosphatase, induced by
glucocorticoids, which inactivates the mitogen-activated
protein kinase (MAPKs) [3,4]. It was reported that the
genetic inhibition of MKP-1 aggravated the inflammation
of an allergic animal model [5] and attenuated the
suppressive effect of dexamethasone (Dex) on several
pro-inflammatory gene expressions in macrophages [6].
Previously, we observed that the inhibitory effect of
dexamethasone on the acetylcholine-induced airway smooth
muscle contraction was dependent on the function of MKP-. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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effect of fluticasone on the Th2 cytokines production in
cultured human T lymphocytes in vitro was mediated by its
induction of MKP-1 expression, which further suppressed
the p38 MAPK activation and the GATA-3 nuclear trans-
location [8]. It was revealed by Furst et al. that the intracel-
lular reactive oxygen species (ROS), which are synthesized
under the stimulation of corticosteroids, initiate the induc-
tion of the MKP-1 expression by GC, through the c-Jun
N-terminal kinase (JNK)-activator protein (AP)-1 pathway
[9]. Since the intracellular redox status is vulnerable to
the exogenous oxidative stress, it sheds light on the hy-
pothesis that the extrinsic oxidants could influence the
inducing process of MKP-1 expression by corticoste-
roids, subsequently interrupting the anti-inflammatory
actions of the drugs.
Mounting evidences support an opinion that oxidative
stress plays crucial roles in the pathogenesis of glucocor-
ticoids insensitivity [10], such as causing defective his-
tone acetylation and GR modification, etc. [1]. However,
few investigations have been conducted to determine
whether the oxidants-mediated disruption of MKP-1
also contributes to the resistance to GCs.
O3 is an exogenous oxidant which adversely affects
human health by irritating the mucosa and harming the
respiratory system [11]; it is particularly deleterious when
encountered by the lungs of asthmatics. We have reported
that acute ozone exposure on a mouse model of allergic
asthma caused the aggravation of the pulmonary inflam-
mation, AHR, and mucus hyperproduction [12]. Using a
chronic allergic asthma model, we found that repeated O3
exposures reduced the response to systemically adminis-
trated dexamethasone of the experimental animals [13].
Furthermore, in a human study researchers reported that
transient exposure to ozone rendered the stable asthmatic
patients more insensitive to the same dosage of inhaled
glucocorticoids, compared with those air-exposed patients
[14]. O3 is a potent stressor, and the exposure of mice to
its influence often causes significant activation of p38
MAPK, which plays a crucial role in the ozone-induced
pulmonary inflammation and AHR [15]. Taken into
account that the over-phosphorylation of p38 MAPK
might be a reflection of impaired dephosphorylation, it
is reasonable to infer that ozone might inhibit the
function of MKP-1. Generally, we hypothesized that the
oxidant ozone might exert some negative effects on the
function of MKP-1, and hence interfere with the anti-
inflammatory action of GCs.
To verify this hypothesis, we employed a murine asthma
model established with ovalbumin (OVA )-induced asthma
model mice, in which the animals were exposed to filtered
air or 1.0 ppm O3 and administered with dexamethasone
in combination with or without a selective p38 MAPK
inhibitor, SB239063. Their evaluation was performedthereafter, including the observation and estimation of
parameters, such as the pulmonary inflammation, AHR,
the phosphorylation of p38 MAPK, and the expression
of MKP-1. The results of the current study indicated
that the inhibitory effect of dexamethasone was com-
promised after the O3 exposure, which was associated
with the O3-enhanced phosphorylation of p38 MAPK
and O3-decreased expression of MKP-1 protein.
Methods
Animals
Six-week-old female Balb/c mice weighting 18 ~ 20 g
were purchased from SLAC Laboratory Animal Co. Ltd.
(Shanghai, China) and bred under specific-pathogen-free
conditions and kept on an ovalbumin (OVA)-free diet in
our own facility.
Ethics statement
This study was carried out in strict accordance with the
recommendations of the Shanghai Committee for Accredit-
ation of Laboratory Animal. The protocol was approved by
the Shanghai First People’s Hospital Institutional Review
Board (Permit Number: 2010KY047). All surgery was
performed under sodium pentobarbital anesthesia, and
all efforts were made to minimize suffering.
OVA sensitization and challenge
The protocol of experimental model establishing was
adopted as previously described [12]. Mice were sensitized
IP with 20 μg chicken OVA (Grade V, Sigma Aldrich Co.,
St. Louis, MO) emulsified in 2.0 mg of alum (Shanghai
No.4 Reagent & H.V. Chemical Industries Ltd., Shanghai,
China) in a total volume of 100 μl of 0.9% sterile saline on
days 1 and 14. Non-sensitized mice just received 2.0 mg of
alum in 0.9% saline. On day 24, 25, and 26, mice received
three aerosol challenges with 5% OVA (wt/vol) (Grade II,
Sigma Aldrich Co., St. Louis, MO) in 0.9% endotoxin-free
saline (non-sensitized mice received saline only) for
30 min daily. Using a plastic box (50 × 30 × 40 cm3) as ex-
posure chamber, where the air was kept at 20 – 22°C and
relative humidity 50 – 60%, the aerosol was generated
by a sidestream jet nebulizer (PARI BOY, Starnberg,
Germany) into the chamber and mice were put into
stainless cages inside the chamber with irradiated food
and acidified water provided ad libitum. One hour
before each challenge, mice received dexamethasone
(2 mg/kg) IP in 0.1 ml endotoxin-free PBS or PBS
alone. The dosage of dexamethasone has been adopted
by multiple publications [16].
Ozone exposure and SB239063 delivery
On days 23, 25 and 27, conscious mice were exposed to
ozone [1.0 parts/million (ppm) for 3 h] or filtered air.
Ozone was generated by directing an air stream with a
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AQUA MEDIC O3 generator (model 300, AB Aqua
Medic GmbH, Bissendorf, Germany). Ozone concentra-
tion in the chamber was monitored continuously by an
Ozone Switch (OS-4, Newark, USA), which also con-
trolled the operation of the ozone generator in response
to the instantaneous value. The target O3 concentration
range was set as 0.77 ppm ~ 1.32 ppm, which has been
proved by our preliminary experiment to be able to
maintain a comparatively stable O3 concentration aver-
aged as 1.01 ± 0.02 ppm (data not shown). This method-
ology of O3 exposure has been adapted by previous
study which had documented that, such level of ozone
inhalation can induced the airway inflammation but not
influence the body weight of mice [17], which means less
toxic effect. One hour before and 4 hrs after the O3
exposure, mice were injected through tail vein SB239063
(Sigma Aldrich, St. Louis, MO) dissolved in 3% DMSO
(0.1 ml, Sigma Aldrich, St. Louis, MO) or DMSO only,
respectively. The dosages of SB239063 were titrated in a
preliminary experiment, where the final dosage of 4.0 mg/kg
was selected. The present experimental protocol was
outlined in Figure 1.
Airway responsiveness testing
Airway responsiveness was assessed noninvasively using
a whole-body plethysmography (Buxco., NY, USA) in
conscious, unrestrained mice as described previously
[18]. Briefly, in day 28, mice were placed in individual
chambers. After ten minutes adaptation they were ex-
posed to aerosolized PBS (to establish baseline), followed
by increasing concentrations of aerosolized methacho-
line (Mch, Sigma Aldrich, St. Louis, MO) (1.5625, 3.125,
6.25, 12.5, 25, 50 mg/ml). Each dose of Mch was deliv-
ered for 0.5 minute, and respiratory measurements were
recorded and averaged over a 7-minute period from the be-
ginning of nebulization. Airflow obstruction was expressed
as enhanced pause (Penh), which correlates well with airwayFigure 1 Schematic diagram of experimental protocol. Mice were sens
saline. Dexamethasone or saline was administrated intraperitoneally 1 hr be
to 1.0 ppm O3 or filtered air for 3 consecutive hrs on day 23, 25 and 27. In
injected through tail vein with SB239063 or DMSO. On day 28, measureme
cytokines, lung tissues for pathological staining and biological testing.resistance, and calculated as: Penh = {[Te (expiratory time)/
Tr (relaxation time)]-1} × [Pef (peak expiratory flow)/Pif
(peak inspiratory flow)]. Penh after each concentration was
expressed as percentage change from baseline. The log
concentrations of MCh required to increase Penh by 100%
from baseline was calculated (LogPC100Penh).
Bronchoalveolar lavage and measurements of BALF
cytokines
Immediately after the assessment of airway reactivity,
mice were sacrificed by an overdose injection of pento-
barbital (500 mg/kg i.p). The tracheal was exposed and
intubated with PE-60 tubing (0.72-mm inner diameter,
1.22-mm outer diameter). Three aliquots of 0.3 ml steril-
ized saline were instilled and retrieved as the bronchoal-
veolar lavage fluid (BALF). Return volume was recorded
and was consistently > 60% of the instilled volume. The
BALF was then centrifuged at 1000 × g for 10 min at 4°C.
The supernatant was aliquoted and stored at −80°C until
assay. The remaining cell pellet was resuspended in 1 ml
PBS solution. Total cell counts were determined using
a haemocytometry, by adding 100 μl of the cell suspen-
sion to 100 μl trypan blue stain. Differential cell counts
were performed on cytocentrifuge preparations (Cytos-
pin 2; Shandon, UK) stained with Wright-Giemsa by
counting 200 cells under × 400 magnification from each
individual by the same inspector in a blinded manner.
Cells were identified by standard morphology and dif-
ferentiated into neutrophils, eosinophils, lymphocytes,
and macrophages.
Concentrations of soluble mediators in BALF superna-
tants were determined by enzyme-linked immunosorbent
assay (ELISA), as previously described [19]. Measurements
of IFN-γ, IL-6 and IL-13 were performed by using commer-
cial kits (R&D Systems China Co. Ltd., Shanghai, China),
following the manufacturer’s protocol. The limits of detec-
tion were 3 pg/ml for IL-6 and IL-13, and 10 pg/ml for
IFN-γ.itized at day 1 and 14, and challenged at day 24, 25, 26 with OVA or
fore each challenge. Equal number of mice were selected to expose
p38 MAPK inhibition experiment, same amount of animals were
nts were performed including enhanced pause (Penh), BAL cells and
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inflammation
After BAL, the left lung lobe was removed and placed in
10% neutral-buffered formalin solution and embedded
into paraffin. The remains were microdissected and
placed into liquid nitrogen and then kept in −80°C until
further process. Four-micrometer paraffin sections were
placed onto Fisher PLUS slides. After deparaffinization
and rehydration, some paraffin sections were stained
with hematoxylin and eosin (H&E), dehydrated, and
mounted.
Slides were coded and graded by two independent
investigators in a blinded fashion using a reproducible
scoring system described elsewhere [20]. A value from 0
to 3 per criterion was adjudged to each tissue section
scored. Two criteria were scored to document the pul-
monary inflammation: peribronchial inflammation and
perivascular inflammation. A value of 0 was adjudged
when no inflammation was detectable, a value of 1 for
occasional cuffing with inflammatory cells, a value of 2
for most bronchi or vessels surrounded by thin layer
(one to five cells) of inflammatory cells and a value of 3
when most bronchi or vessels were surrounded by a
thick layer (more than five cells) of inflammatory cells.
Total lung inflammation was defined as the average of
the peribronchial and perivascular inflammation scores.
2 ~ 3 tissue sections per mouse were scored, and the
inflammation scores was expressed as a mean value of
15 ~ 20 sections per group.
Immunoblotting
Mouse lung tissues were first incubated in ice-cold 1 × cell
lysis buffer(Cell signaling technology, Mass., US) plus
1 mM PMSF and a protease inhibitor cocktail (Sigma
Aldrich, St. Louis, MO), as well as a serine/threonine
phosphatase inhibitor cocktail2 (Sigma-Aldrich, St. Louis,
MO4) for 30 minutes and lysed using Fastprep system
(MP Biomedicals, Germany). The Homogenates were cen-
trifuged at 15,000 × g for 15 minutes at 4°C and the con-
centration of proteins in the supernatants fractions was
determined by BCA Protein Assay Kit (Pierce, Thermo
Scientific Co, US). Equal amounts of protein (75 μg) from
blindly selected samples were renumbered and subjected
to 10% SDS–PAGE. Separated proteins were transferred
to PVDF membranes (iBlot™ Dry Blotting System, Invitro-
gen) after electrophoresis at 90 V for 7 min. Membranes
were blocked with 5% nonfat dry milk dissolved in TBST
buffer (10 mM Tris–HCl (pH 7.5), 150 mM NaCl, 0.1%
Tween-20) overnight at 4°C. Binding of the primary anti-
body was detected by infrared dye-conjugated secondary
antibodies and Odyssey system (Li-Cor, USA), and the
bands were quantified with densitometry. The source of
the antibodies and dilutions used were as follows: mouse
anti-p38 MAPK (1:5000 dilution), mouse anti-phospho-p38 MAPK (1:5000 dilution) (Cell Signaling Technology,
Mass., US), mouse anti-phospho-MKP-1 (1:4000 dilution)
and mouse anti-α-actin (1:1000 dilution) (Sigma Aldrich,
St. Louis, MO).
Real-time reverse transcription-polymerase chain reaction
Total RNA was extracted using the TRIzol® Reagent
(Invitrogen, Calif. US) according to the manufacturer’s
instruction. RNA (2 μg per sample) was used to synthe-
sise single-stranded complimentary DNA (cDNA) using
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, CA, USA) in a PTC-200 Peltier Thermal Cycler
(MJ Research, Watertown, Mass., USA). The cDNA gener-
ated was used as a template in subsequent real-time PCR
analyses. Transcript levels were determined by Applied
Biosystems 7500 Real Time PCR System (Applied Bio-
systems, CA, USA) using SYBR Green PCR Master Mix
Reagent (Qiagen, Germany). The sequences of murine
forward and reverse primers used are displayed in
Table 1 (Devised by Invitrogen Shanghai Ltd. China).
The thermal cycling program of qPCR was as follows:
Step 1, 15 min at 95°C; step 2, 15 s at 95°C; step 3: 30 s
at 60°C; step 4: 30 s at 72°C, with step 2 to step 4 re-
peated for 40 cycles. Relative gene expression was nor-
malized to β-actin. Data are expressed as fold-increase
in RNA expression compared with control animals,
which are set at a value of 1.
Measurement of bio-markers of oxidative stress
Malondialdehyde (MDA) level was utilized to quantify
the lipid peroxidation in tissues as previously described
[21]. Briefly, following lung homogenate preparation,
MDA content was based on the reaction of MDA with
thiobarbituric acid (Nanjing Jiancheng Bioengineering
Institute, Jiangsu, China) at 95°C. Samples were then
heated for 1 h at 95°C and centrifuged at 3000 g for
10 min. The absorbance of the supernatant was mea-
sured by spectrophotometry at 532 nm using 1,1,3,3-tet-
ramethoxypropane as an external standard. MDA was
expressed in micromole per g weight of wet tissue.
Glutathione peroxidase (GSH-Px) activity in lung su-
pernatants was determined spectrophotometrically with
minor modification of methods previously described
[22]. The rate of GSSG formation was assessed by
measuring the reduction of GSH (Nanjing Jiancheng
Bioengineering Institute, Jiangsu, China). The unit of
GSH-Px activity was defined as μmpl/L reduced GSH · g
protein−1 · min−1.
Statistical analysis
Data are expressed as mean ± standard error of the mean
(SEM). One-way ANOVA was used to determine the
statistical significance of differences among groups. S-N-
K test was used to correct for multiple comparisons
Table 1 Sequences of target genes
primer Forward primer Reverse primer
IL-5 5′-CCATGCAGAGTCCTCAGAAC AA-3′ 5′- TTACTGGAA AGGCCCAAG CA-3′
IL-17 5′- CCTGGCGGCTACAGTGAAG-3′ 5′- TTTGGACACGCTGAGCTTTG-3′
TNF-α 5′-AGCCGATGGGTTGTACCTTGTC TA-3′ 5′-TGAGATAGCAAATCGGCTGACGGT-3′
CXCL1 5′-TGGCTGGGATTCACCTCAAGAACA-3′ 5′-TGTGGCTATGACTTCGGTTTGGGT-3′
MKP-1 5′-CTGCCTTGATCAACGTCTCA-3′ 5′-ACCCTTCCTCCAGCATTCTT-3′
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ANOVA. Comparisons within each group are made by
unpaired t-test. Criterion for significance was taken to
be p ≤ 0.05. For statistical analysis, SPSS program (SPSS
Inc. Chicago, IL, USA) was used. For statistical charting,
GraphPad Prism 5.0 (GraphPad Software Inc., San
Diego, CA) was used.Results
Ozone impaired the inhibitory effects of dexamethasone
on lung inflammation and AHR
As expected, compared with the normal controls, mice in
the asthma model exhibited AHR (decreased LogPC100-
Penh), higher BAL number of total cells, lymphocytes,
eosinophils and neutrophils, elevated BAL concentration
of IFN-γ, IL-6 and IL-13, as well as higher pathological in-
flammatory score and mRNA expressions of inflammatory
cytokines (TNF-α, IL-5, CXCL-1 and IL-17) in lung tis-
sues (Figure 2). Subsequent intraperitoneal administration
of dexamethasone (2 mg/kg), but not saline, significantly
decreased the AHR, lowered the number of total cells and
eosinophils, decreased the BAL concentration of IFN-γ
and IL-6, attenuated the pathological inflammation and
the mRNA expression of IL-5 in lung tissues (Figure 2).
In comparison with their air-exposed counterparts,
O3-exposed asthmatic mice had significantly enhanced
AHR, increased BAL number of neutrophils and BAL
concentration of IL-13, aggravation of lung inflamma-
tion, and prominent elevations in lung mRNA expres-
sions of TNF-α, CXCL-1 and IL-17(Figure 2).
Combined administration of dexamethasone on O3-
exposed asthmatic mice failed to elicit any significant
variation on AHR or pulmonary inflammation (Figure 2).Ozone increased oxidative stress and p38 MAPK
phosphorylation and differentially influenced MKP-1 gene
and protein expression
As a potent exotic oxidant, O3 might exert influence on
the intrinsic oxidative metabolism. We measured the
MDA concentration and the GSH-Px activity in lung tis-
sues and found that the asthmatic mice exhibited higher
level of MDA concentration and lower extent of GSH-
Px activity than their normal controls. Ozone exposure fur-
ther significantly intensified the trends of both biomarkers.Further administration of dexamethasone changed neither
of them (Figure 3A and B).
To find out whether the p38 MAPK and its phosphat-
ase, MKP-1, get involved in the O3 interference with the
dexamethasone effect, we evaluated the phosphorylation
ratio of the p38 MAPK and the expression of MKP-1.
Data showed that the activation of p38 MAPK was
prominent in asthma model, in contrast with their nor-
mal controls. Ozone exposure on asthma model further
enhanced the phosphorylation of p38 MAPK. Administra-
tion of dexamethasone on these model animals slightly
decreased the phosphorylation ratio of p38 MAPK (saline
0.762 ± 0.232 vs dexamethasone 0.273 ± 0.081, p = 0.070).
This trend was obscured when the experimental animals re-
ceived the O3 exposure simultaneously (saline 2.571 ± 0.308
vs dexamethasone 2.378 ± 0.302, p= 0.663) (Figure 3C).
To evaluate the MKP-1 protein expression level, we
measured the phosphorylated protein of this phosphat-
ase, for the phosphorylation promotes its stability and
otherwise it is quickly degraded and hence transient
[23,24]. Our data showed that both the protein and the
mRNA expression of MKP-1 were elevated in allergic
mice exposed to air, while the identical group of mice
exposed to O3 exhibited higher expression of MKP-1 at
mRNA level but not at protein level. Administration of
dexamethasone on the air-exposed experimental animals
increased the expression of MKP-1 at both levels, while
this effect was diminished when these asthmatic mice
received combined ozone inhalation (Figure 3D and E).
SB239063 restored partly the ozone-impaired effects of
dexamethasone
To further demonstrate the involvements of p38 MAPK
in the ozone-induced inhibition of glucocorticoids ef-
fects, an inhibitor of p38 MAPK, SB239063, was admin-
istrated in mice before and after each O3 exposure. The
dosage of SB239063 were titrated in a preliminary experi-
ment, in which three dosages of SB239063 (0.4 mg/kg,
1.2 mg/kg, 4 mg/kg; diluted with DMSO) and DMSO
alone were randomly injected through tail vein in mice
exposed 1.0 ppm ozone for 3 hours (usage referred to
the previous study [25]). Some measurements were
performed including BAL cells and AHR to evaluate
the dose-dependent inhibitory effects of SB239063. The
data showed that, compared with DMSO alone and
Figure 2 Ozone inhalation impaired the inhibitory effects of dexamethasone on AHR and lung inflammation. Twenty-eight mice were
sensitized and challenged with OVA and then exposed to 1.0 ppm ozone or filtered air for 3 hrs. Equal amounts of mice in each group (7) were
selected to receive intraperitoneal injection either with dexamethasone (2 mg/kg) or with saline only. A: Mean percentage increase in enhanced
pause (Penh) to increasing provocative concentrations of Mch. B: log provocative concentration of Mch required to increase Penh from baseline to
100% (LogPC100Penh). C: changes in total cells and differential cellularity of BALF. D: BAL cytokines tested by ELISA. E: typical changes of haematoxylin
staining of lung sections, red arrow: inflammatory cells surrounding vascular; black arrow: inflammatory cells surrounding bronchiole. B: bronchiole,
V: vascular. F: Inflammation grades in peribronchial and perivascular area of lung seections. G: mRNA expression of inflammatory genes. *:p < 0.05;
**:p < 0.01; ***: p < 0.001; n = 7.
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Figure 3 Ozone induced oxidative stress and changes of phosphorylation of p38 MAPK and expression of MKP-1 in lung tissues.
A: Malondialdehyde (MDA) concentration in lung tissues supernatants measured spectrophotometrically. B: Activity of Glutathione peroxidase
(GSH-Px) in lung tissue supernatants measured by spectrophotometry. C: Western blot analysis of phosphorylated and non-phosphorylated p38
MAPK. The activation of p38 MAPK was determined by the ratio between phospho- and non-phospho- p38 MAPK. The bands were cut from the
film where the samples were blindly subjected to polyacrylamide gel electrophoresis and rearranged accordingly. D: Western blot analysis of
phosphorylated MKP-1 (p-MKP-1) in lung tissues. This was determined as a ratio against β-actin. Band densities were determined and results
plotted graphically for the 7 animals in each group. E: Fold change of MKP-1 mRNA in lung tissues tested by quantitative RT-PCR (n = 7). *:p < 0.05;
**:p < 0.01; ***: p < 0.001.
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decreased the number of BAL total cells (O3: 400.00 ±
75.86 vs O3 + SB2390634mg/kg: 170.00 ± 24.06, p = 0.028)and macrophages (O3: 367.41 ± 69.22 vs O3 + SB2390634mg/kg:
156.44 ± 46.40, p = 0.028), and slightly inhibited the
ozone-induced AHR (O3: 0.315±0.118 vs O3+SB2390634mg/kg:
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Accordingly, 4 mg/kg was adopted as the dosage of
SB239063 during the subsequent experiment.
Data showed that SB239063 in O3-exposed asthmatic
mice significantly inhibited the AHR, decreased the
number of BAL neutrophils and concentrations of IL-6
and IL-13, alleviated the perivascular lung inflammation
and down-regulated the lung IL-17 mRNA expression.
Furthermore, upon the delivery of SB239063 but not
DMSO only, the administration of dexamethasone elic-
ited some inhibitory effects on the AHR, the number of
BAL total and eosinophil cells, the peribronchial lung
inflammation, and the lung expression of IL-5 mRNA in
O3-exposed asthmatic mice (Figure 4).
SB239063-induced changes in oxidative stress, the p38
MAPK phosphorylation and the expression of MKP-1
SB239063 affected neither the concentration of MDA
nor the activity of GSH-Px in O3-exposed asthmatic
mice (Figure 5A and B).
Compared with DMSO only, SB239063 significantly
decreased the phosphorylation ratio of p38 MAPK, but
not influenced the mRNA or the protein expression of
MKP-1, in lung tissues of O3-exposed asthmatic mice
(Figure 5C, D and E). However, upon the delivery of
SB239063, further administration of dexamethasone caused a
slight non-significant increase in the protein (SB2390634mg/kg:
0.656 ± 0.088 vs DMSO: 0.423 ± 0.084, p= 0.079) and mRNA
(SB2390634mg/kg: 7.922 ± 1.427 vs DMSO: 5.093 ± 0.591,
p = 0.092) expression of MKP-1, in O3-exposed asth-
matic mice (Figure 5D and E).
Discussion
As expected, the mice of the present allergic asthma
model exhibited AHR, eosinophilic airway inflammation,
and elevated BAL and lung immunological cytokines.
Consistently with other reports, the enhanced phosphor-
ylation of p38 MAPK was observed in the present ani-
mal model, which may indicate the participation of this
kinase in the pathophysiological process of anaphylaxis
[26,27]. Interestingly, the protein and gene expression
levels of MKP-1 in the lungs of the experimental animals
were also elevated. This phenomenon, which has not
been reported heretofore, provides a clue that the p38
MAPK and MKP-1 might balance each other at a com-
paratively elevated baseline level within such an asthma
model. Exposing these experimental animals to ozone
enhanced the AHR, induced the neutrophilic airway in-
flammation, promoted the expressions of Th1 and Th17
cytokines in BAL and lung tissues, and increased the
oxidative stress levels. These aggravating effects of ozone
on the allergic animals have been demonstrated previ-
ously by other researchers and ourselves [12,28,29]. The
activated p38 MAPK pathway is the cornerstone of theozone-induced detrimental effects both on the AHR and
airway inflammation in mice [7,15]. In the present study,
we illustrated that the inhibition of p38 MAPK signifi-
cantly eliminated the adverse activities of ozone on the
AHR and airway inflammation as well as on most of the
inflammatory cytokines, such as IL-6 and IL-13 in BAL,
and IL-17 in the lung tissues of the asthmatic mice
(Figure 4). It is reasonable to come to a conclusion that
the p38 MAPK pathway plays central roles in the influ-
ence of ozone on current asthma model. However, the
mRNA expressions of several inflammatory cytokines,
such as CXCL-1 and TNFα, cannot be inhibited by
SB239063, which may indicate that the expressions of
these pro-inflammatory cytokines, whether being in-
duced by allergic inflammation or by ozone stimulation,
are regulated by an exceedingly complicated crosstalk
network in which the p38 MAPK pathway is subtly in-
volved. However, whether the oxidant ozone affects the
therapeutic effects of corticosteroids on this allergic
experimental model has not been reported yet.
The inhibitory effects of dexamethasone on the current
experimental model were evidenced by the decreased
AHR (increased LogPC100Penh), attenuated airway in-
flammatory cellularity and pathologic alleviation of the
lung inflammation (peri-bronchial and peri-vascular
area) as well as by the lowered mRNA expression of
Th2 cytokines (IL-5) in the lungs. Interestingly, these
dexamethasone-induced alterations were diminished in
the mice of identical background airway inflammation
but received the O3 exposure simultaneously with the
medication. Accordingly, it can be modestly inferred
that the subacute ozone exposure in the present study
impaired the inhibitory effects of dexamethasone on
this classical allergic asthma model. In other words, the
ozone exposure blunted the response to the corti-
cotherapy of these allergic mice.
The underlying mechanisms of the ozone-decreased
biological response to glucocorticoids action remain
unclear. However, we found in current study that the O3
exposure of the asthmatic mice caused four main specific
alterations differing from their air-exposed counterparts.
These particular features, namely the airway neutrophilia,
enhanced activation of p38 MAPK, upregulated expression
of IL-17, and altered expression of MKP-1, may lead to the
resistance to the subsequent delivery of dexamethasone.
Neutrophils are generally considered less responsive to
GCs compared to other inflammatory cells [30]. The
neutrophilic inflammation existing in the context of
some chronic conditions, such as the chronic obstructive
pulmonary disease (COPD) and chronic asthma, tends
to be resistant to corticotherapy, whether in human pa-
tients [10,31] or in experimental animals [32]. However,
it does not mean that neutrophils are resistant to GCs
by nature, for Hirsch et al. reported that neutrophils are
Figure 4 SB239063 partly restored the ozone-impaired inhibitory effects of dexamethasone. Twenty-eight asthmatic mice were exposed
to 1.0 ppm ozone for 3 hrs. Then equal number of mice (14) received injection of SB239063(4.0 mg/kg, diluted by DMSO) or DMSO only 1 hr before
and 4 hr after each O3 exposure. Half number of mice (7) in each group received intraperitoneal injection with dexamethasone (2.0 mg/kg) or saline
only 1 hr before each aerosol challenge. Interpretation of A to G is same as Figure 2. *:p < 0.05; **:p < 0.01; ***: p < 0.001; n = 7.
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Figure 5 SB239063 caused changes in oxidative stress and the phosphorylation of p38 MAPK and the expression of MKP-1 in lung
tissues. Interpretation of A) to E) is same to those in Figure 3. *:p < 0.05; **:p < 0.01; ***: p < 0.001; n = 7.
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glucocorticoids on the expressions of pro-inflammatory
genes in peripheral blood mononuclear cells (PBMCs) of
normal subjects [33]. Since the current study did not
measure the direct response of neutrophils to the applica-
tion of glucocorticoids, our data cannot offer further
supporting information on whether a subacute oxidative
stress conditions, as created in the present investigation,might render the accumulated neutrophils resistant to
corticosteroids. However, some neutrophil-related cyto-
kines, such as TNF-α, were proved to be insensitive to
dexamethasone, as shown in this examination (Figure 2G).
It has been previously reported by Onda et al. that TNF-α
can reduce the GC-induced transactivation of endogenous
genes as well as that of a reporter plasmid which contains
a GC responsive element (GRE) in cultured human
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demonstrated that TNF-α not only impaired the GR-
dependent gene expression, but also downregulated the
levels of both GR mRNA and protein [35]. Given the
intimate relationship between TNF-α and neutrophils, it
is reasonable to infer that the contribution of neutrophils
to the GC insensitivity may involve the function of TNF-α.
In addition to boosting airway neutrophils, ozone expos-
ure on present asthma model caused significant activation
of p38 MAPK, a kinase involved in the pathogenesis of
both the allergic and the ozone-induced airway inflamma-
tion and AHR [15,26]. In this study, we demonstrated that
the inhibition of p38 MAPK not only mitigated the aggra-
vating effects of O3 on pulmonary inflammation and
AHR, but also restored partly the O3-impaired inhibitory
effects of dexamethasone. Although numerous examina-
tions have indicated that the inhibition of p38 MAPK can
promote the cellular response to corticosteroids in vitro
[36-38], demonstrating the roles of this kinase in the
pathogenesis of glucocorticoids insensitivity, the current
investigation confirmed this viewpoint in vivo. The phos-
phorylation of GRα by the activated p38 MAPK in PBMCs
is reported to contribute to the glucocorticoids insensitiv-
ity of severe asthmatic patients [39]. Besides, p38 MPAK
might also exert its roles through its downstream regula-
tory molecules, such as IL-17.
As reported previously, the expression of IL-17 mRNA
can be upregulated by ozone exposure [17,40,41]. How-
ever, it is by far not known how ozone initiates the
upregulation of this Th17 cytokine. The results of the
present research showed that the O3-elevated IL-17
mRNA expression was decreased by the SB239063, sug-
gesting the critical functions of the activated p38 MAPK
executed in the course between the O3 exposure and IL-
17 expression. Besides, the pivotal roles of p38 MAPK in
the synthesis of IL-17 by CD4 (+) cells have been vali-
dated by previous studies [42,43]. Overall, we have rea-
sons to infer that the p38 MAPK pathway might
contribute to the ozone-induced upregulation of IL-17.
This hypothesis is worthwhile and needs to be further
substantiated in vitro.
Th17 cells and cytokines play pivotal roles in the
ozone-induced airway hyperresponsiveness in mice [17].
Interestingly, the AHR of mice, induced by the transfer
of Th17 cytokines or Th17-cells, is susceptible to be-
coming insensitive to the inhibition effects of dexa-
methasone [44]. In the current examination, the elevated
expression of IL-17 mRNA was associated with the de-
creased response to dexamethasone in the ozone-exposed
asthmatic mice and vice versa after they received the
administration of BS239063. Actually, the contribution of
Th17 cytokines to the pathogenesis of developing absence
of sensitivity to glucocorticoids has already been con-
firmed by numerous ex vivo investigations [44-46]. Basedon these established contributions of IL-17 to GC insensi-
tivity, it may be hypothesized that O3 exposure of asth-
matic mice may promote the production of IL-17 via the
activation of p38 MAPK pathway, and hence it may
impair the therapeutic effect of dexamethasone.
It is well known that MKP-1 mediates the anti-
inflammatory effects of GCs [4,47-49]. Impairments in
the expression of this phosphatase will compromise the
action of GCs. In the present study, we measured the
phosphorylated MKP-1 protein instead of the total pro-
tein, considering the fact that after its synthesis, the
MKP-1 protein is quickly degraded and hence is transi-
ent, while the phosphorylation by ERK1/2 on its serine
residues, Serine 359 and Serine 364, promotes its
stability and hence possesses phosphatase activity [23].
Moreover, given the common option that extracellular
regulated protein kinases (ERK) 1/2 is involved to a
lower extent in the response to extrinsic stress, it is rea-
sonable to assume that the ozone exposure has an insig-
nificant impact on the phosphorylation of the MKP-1
protein. Hence, the p-MKP-1 protein measured in the
current investigation can be regarded as the response of
the change in the total MKP-1 protein rather than the
variation of the phosphorylation intensity.
Our results demonstrated that GCs induced the
mRNA and protein expression of MKP-1, which is con-
sistent with previous published data [49]. According to
the conclusions originating from an earlier examination
[9], this induction progress is initiated by the intracellu-
lar ROS, of which this course is vulnerable to the outer
source of oxidants. In our study, we observed that the
ozone exposure diminished the favorable influence of
dexamethasone on mRNA and protein expression of
MKP-1 in asthmatic mice. This trend was accompanied
by the ozone-impaired GC therapeutic effects. Further-
more, the blockade of p38 MAPK by SB239063 not only
restored a part of the curative actions of Dex, but also
regained the slight conducive trend of GCs on the expres-
sion of MKP-1. These observations provide inferences that
the impaired GCs induction of MKP-1 expression might
contribute to the ozone-induced GC insensitivity.
Numerous studies have placed their focus on the influ-
ence of oxidative stress on the expression of MKP-1,
mostly in vitro xpeiments [50,51]. However, the manner
in which the oxidative stress influences the expression of
MKP-1 in vivo still remains elusive. In the present ex-
periments, we observed that the O3 exposure in allergic
mice caused higher expression of MKP-1 at the mRNA
level, but, unexpectedly, not at the protein level. Al-
though previous research illustrated that p38 MAPK
mediates the oxidative stress-induced MKP-1 mRNA
expression in vitro [50], we demonstrated that the inhib-
ition of p38 MAPK did not prevent the transcriptional
induction of MKP-1 mRNA by O3 in vivo. The
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of MKP-1 needs to be further explored in different
systems with diverse stimuli. However, this is the first
report, which highlights the ozone-induced discrepant
alterations between the mRNA and the protein expres-
sion of MKP-1. The biological basis for this discrepancy
is by far not clear. According to Kuwano et al., the H2O2
treatment promotes the translation of MKP-1 by in-
creasing the association of the MKP-1 mRNA with its
binding protein HuR and NF 90 in cultured HeLa cells
[52]. However, the oxidative modification of MKP-1 pro-
tein, promoted by oxidative stress, not only inactivates
MKP-1 but also targets this phosphatase for proteasomal
degradation [53]. Furthermore, though the proper intra-
cellular activation of ERKs contributes to the phosphor-
ylation and the stability of the MKP-1 protein, the
sustained activation of ERKs causes the degradation of
MKP-1 protein via the ubiquitin-proteasome pathway
[54]. Overall, we defined a hypothesis that this differen-
tial influence on the MKP-1 protein may result from the
O3-enhanced oxidative stress-related post-translational
modification, which needs to be further substantiated.
Conclusions
In summary, present study demonstrated that ozone in-
halation impaired the therapeutic effects of dexametha-
sone on AHR and airway inflammation of mice with
allergic airway disease, which can be reversed by the
inhibition of p38 MAPK. The pathophysiological basis
underlying the ozone-induced declining sensitivity to
GCs may involve the over phosphorylation of p38
MAPK, which may further mediate the upregulated IL-
17 expression, and the elevated oxidative stress, which
may disturb the GCs induction of MKP-1 expression
and promote the degradation of MKP-1 protein. This
study put forward an alternative explanation for the
ozone oxidative stress induced insensitivity to glucocor-
ticoids therapy, and provide the identification of new
therapeutic targets which may aid in the management of
patients with steroids-resistant asthma.
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